by newsworm | Mar 11, 2025 | Glenmark, Pharma
Glenmark Therapeutics Inc., a US-based company, has announced the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams/capful (OTC), a product that is comparable to the active ingredient in MiraLAX Powder for Solution, 17 grams from Bayer HealthCare LLC.... by newsworm | Mar 9, 2025 | Glenmark, Pharma
Mahavir International’s “Project Vatsalya – Pregnancy to Infancy” has been recognized for its outstanding efforts in eradicating malnutrition among women and children. The initiative received the prestigious Glenmark Nutrition Award 2025, which comes... by newsworm | Mar 5, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals has issued another recall, this time for approximately 1.5 million bottles of its generic attention deficit hyperactivity disorder (ADHD) medication, Strides Proudly Managed By Strides. The recall is due to potential irregularities in the... by newsworm | Feb 28, 2025 | Glenmark, Pharma
Glenmark Pharmaceuticals, a Mumbai-based company, has announced the launch of its generic version of Epinephrine injection multiple-dose vial in the US market. This product is eligible for 180 days of competitive generic therapy (CGT) exclusivity. The injection is... by newsworm | Feb 15, 2025 | Glenmark, Pharma
Glenmark’s Telma brand, containing Telmisartan, has been a leading name in the treatment of hypertension, heart failure, and prevention of heart attack and stroke for two decades. The brand’s strength can be attributed to its strong brand identity, which... by newsworm | Feb 12, 2025 | Glenmark, Pharma
Glenmark, a leading Indian pharmaceutical company, has launched Clindamycin Phosphate Foam, a bioequivalent to Evoclin (Barr Pharmaceuticals, Inc.), a popular topical corticosteroid used to treat inflammatory skin conditions. The new product, Clindamycin Phosphate...